Search Results - J. Zeidner

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    S132: TOLERABILITY AND EFFICACY OF THE FIRST-IN-CLASS ANTI-CD47 ANTIBODY MAGROLIMAB COMBINED WITH AZACITIDINE IN FRONTLINE PATIENTS WITH TP53-MUTATED ACUTE MYELOID LEUKEMIA: PHASE... by N. G. Daver, P. Vyas, S. Kambhampati, M. M. Al Malki, R. Larson, A. Asch, G. Mannis, W. Chai-Ho, T. Tanaka, T. Bradley, D. Jeyakumar, E. Wang, G. Xing, M. Chao, G. Ramsingh, C. Renard, I. Lal, J. Zeidner, D. Sallman

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  2. 2

    P519: TRANSFUSION INDEPENDENCE AMONG NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS RECEIVING VENETOCLAX-BASED COMBINATIONS VS OTHER THERAPIES: RESULTS FROM THE AML REAL WORLD EVI... by O. Wolach, J. S. Garcia, P. Vachhani, J. Zeidner, C. Lai, Y. Moshe, M. Xavier, S. Lee, T. Zuckerman, D. A. Pollyea, S. Abedin, E. C. Chen, S. Bathini, W. Edwards, C. N. Bui, W. W.-H. Cheng, A. Svensson, A. Guérin, J. Maitland, E. Ma, M. Montez, M. Grunspan, A. D. Goldberg

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


  3. 3

    P526: REAL-WORLD COMPARISON OF DIFFERENT TREATMENT MODALITIES FOR FAVORABLE RISK ACUTE MYELOID LEUKEMIA: STANDARD DOSE ANTHRACYCLINE VS HIGH DOSE ANTHRACYCLINE VS ADDITION OF GEMTU... by J. Mort, B. Brewer, B. Mautner, S. Dibenedetto, E. Pierce, E. Morse, L. Wells, F. Ghamsari, A. Morris, S. Clark, J. Reid, I. Patel, C. Jackson, M. Perciavalle, B. Yelvington, R. Miller, K. Abernathy, H. Wolfe, S. Locke, J. Zeidner, D. Reed, V. Duong, B. Dholaria, T. LeBlanc, M. Keng, B. Horton, F. El Chaer

    Published in HemaSphere (2022-06-01)
    Get full text
    Article


Search Tools: